*EISAI-E7080-G000-303

Study Sponsor: Eisai

Study Title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Lenvatinib (E7080) in 131I-Refractory Differentiated Thyroid Cancer

Medicine or Vaccine (generic name)

lenvatinib

Sponsor Identification Number

E7080-G000-303

Trial Registry Identification Number(#'s)

NCT01321554
EU CTR 2010-023783-41

Medical Condition

Thyroid Cancer

Phase

Phase 3

Link to study details on the Eisai Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Additional information about the data and documents available for this study

Sharing of clinical data is prevented for the following countries; Germany, France, Sweden, Poland, due to ICF restrictions.

Date Added to this Site

August 2015